1 Chen Y,Cui Z,Xiao Z,et al.PAX1 and SOX1 methylation as an initial screening method for cervical cancer:a meta-analysis of individual studies in Asians.Ann Transl Med,2016,4:365.
2 Li N,He Y,Mi P.ZNF582 methylation as a potential biomarker to predict cervical intraepithelial neoplasia type III/worse:A meta-analysis of related studies in Chinese population.Medicine,2019,98:e14297.
3 Kan YY,Liou YL,Wang HJ,et al.PAX1 methylation as a potential biomarker for cervical cancer screening.Int J Gynecol Cancer,2014,24:928-934.
4 Fang C,Wang SY,Liou YL,et al.The promising role of PAX1 (aliases:HUP48,OFC2) gene methylation in cancer screening.Mol Genet Genomic Med,2019,7:e506.
5 Xu L,Xu J,Hu Z,et al.Quantitative DNA methylation analysis of paired box gene 1 and LIM homeobox transcription factor 1 α genes in cervical cancer.Oncol Lett,2018,15:4477-4484.
6 Chen Y,Cui Z,Xiao Z,et al.PAX1 and SOX1 methylation as an initial screening method for cervical cancer:a meta-analysis of individual studies in Asians.Ann Trans Med,2016,4:365.
7 Su HY,Lai HC,Lin YW,et al.An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.Int J Cancer,2009,124:387-393.
8 Kiefer JC.Back to basics:Sox genes.Dev Dyn,2007,236:2356-2366.
9 Apostolidou S,Hadwin R,Burnell M,et al.DNA methylation analysis in liquid-based cytology for cervical cancer screening.Int J Cancer,2009,125:2995-3002.
10 Rogeri CD,Silveira HCS,Causin RL,et al.Methylation of the hsa-miR-124,SOX1,TERT,and LMX1A genes as biomarkers for precursor lesions in cervical cancer.Gynecol Oncol,2018,150:545-551.
11 Urrutia R.KRAB-containing zinc-finger repressor proteins.Genome Biol,2003,4:231.
12 Huang RL,Chang CC,Su PH,et al.Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasms.PloS One,2012,7:e41060.
13 Li N,He Y,Mi P.ZNF582 methylation as a potential biomarker to predict cervical intraepithelial neoplasia type III/worse:A meta-analysis of related studies in Chinese population.Medicine,2019,98:e14297.
14 Pehlivan S,Artac M,Sever T,et al.Gene methylation of SFRP2,P16,DAPK1,HIC1,and MGMT and KRAS mutations in sporadic colorectal cancer.Cancer Genet Cytogenet,2010,201:128-132.
15 石雪,高宏宇,燕玮,等.EGCG对急性早幼粒细胞白血病细胞株NB4增殖、细胞周期及DAPK1基因甲基化影响的研究.中国实验血液学杂志,2018,26:1288-1293.
16 Bialik S.DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death.Semin Cancer Biol,2004,14:283-294.
17 Cronje HS.Screening for cervical cancer in developing countries.Int J Gynaecol Obstet,2004,84:101-108.
18 Xiong J,Li Y,Huang K,et al.Association between DAPK1 promoter methylation and cervical cancer:a meta-analysis.PloS One,2014,9:e107272.
19 Agodi A,Barchitta M,Quattrocchi A,et al.DAPK1 Promoter Methylation and Cervical Cancer Risk:A Systematic Review and a Meta-Analysis.PloS One,2015,10:e0135078.